BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 34767070)

  • 21. Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics.
    Fancy NN; Smith AM; Caramello A; Tsartsalis S; Davey K; Muirhead RCJ; McGarry A; Jenkyns MH; Schneegans E; Chau V; Thomas M; Boulger S; Cheung TKD; Adair E; Papageorgopoulou M; Willumsen N; Khozoie C; Gomez-Nicola D; Jackson JS; Matthews PM
    Acta Neuropathol; 2024 May; 147(1):78. PubMed ID: 38695952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.
    Mohri I; Kadoyama K; Kanekiyo T; Sato Y; Kagitani-Shimono K; Saito Y; Suzuki K; Kudo T; Takeda M; Urade Y; Murayama S; Taniike M
    J Neuropathol Exp Neurol; 2007 Jun; 66(6):469-80. PubMed ID: 17549007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques.
    Natunen T; Martiskainen H; Marttinen M; Gabbouj S; Koivisto H; Kemppainen S; Kaipainen S; Takalo M; Svobodová H; Leppänen L; Kemiläinen B; Ryhänen S; Kuulasmaa T; Rahunen E; Juutinen S; Mäkinen P; Miettinen P; Rauramaa T; Pihlajamäki J; Haapasalo A; Leinonen V; Tanila H; Hiltunen M
    Mol Neurodegener; 2020 Nov; 15(1):66. PubMed ID: 33168021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.
    Sheng JG; Mrak RE; Griffin WS
    Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
    Hüttenrauch M; Ogorek I; Klafki H; Otto M; Stadelmann C; Weggen S; Wiltfang J; Wirths O
    Acta Neuropathol Commun; 2018 Oct; 6(1):108. PubMed ID: 30340518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P2X
    Beltran-Lobo P; Hughes MM; Troakes C; Croft CL; Rupawala H; Jutzi D; Ruepp MD; Jimenez-Sanchez M; Perkinton MS; Kassiou M; Golde TE; Hanger DP; Verkhratsky A; Perez-Nievas BG; Noble W
    Brain Behav Immun; 2023 Nov; 114():414-429. PubMed ID: 37716378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Alzheimer's disease reactive astrocytes exhibit a loss of homeostastic gene expression.
    Dai DL; Li M; Lee EB
    Acta Neuropathol Commun; 2023 Aug; 11(1):127. PubMed ID: 37533101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression Pattern of Scavenger Receptors and Amyloid-β Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer's Disease.
    Eugenín J; Vecchiola A; Murgas P; Arroyo P; Cornejo F; von Bernhardi R
    J Alzheimers Dis; 2016 May; 53(3):857-73. PubMed ID: 27258416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro.
    Mulder SD; Nielsen HM; Blankenstein MA; Eikelenboom P; Veerhuis R
    Glia; 2014 Apr; 62(4):493-503. PubMed ID: 24446231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglial motility in Alzheimer's disease and after Aβ42 immunotherapy: a human post-mortem study.
    Franco-Bocanegra DK; George B; Lau LC; Holmes C; Nicoll JAR; Boche D
    Acta Neuropathol Commun; 2019 Nov; 7(1):174. PubMed ID: 31703599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction.
    Orre M; Kamphuis W; Osborn LM; Jansen AHP; Kooijman L; Bossers K; Hol EM
    Neurobiol Aging; 2014 Dec; 35(12):2746-2760. PubMed ID: 25002035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Traumatic brain injury results in unique microglial and astrocyte transcriptomes enriched for type I interferon response.
    Todd BP; Chimenti MS; Luo Z; Ferguson PJ; Bassuk AG; Newell EA
    J Neuroinflammation; 2021 Jul; 18(1):151. PubMed ID: 34225752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease.
    Park JS; Kam TI; Lee S; Park H; Oh Y; Kwon SH; Song JJ; Kim D; Kim H; Jhaldiyal A; Na DH; Lee KC; Park EJ; Pomper MG; Pletnikova O; Troncoso JC; Ko HS; Dawson VL; Dawson TM; Lee S
    Acta Neuropathol Commun; 2021 Apr; 9(1):78. PubMed ID: 33902708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease.
    Singh D
    J Neuroinflammation; 2022 Aug; 19(1):206. PubMed ID: 35978311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease.
    Thangavel R; Stolmeier D; Yang X; Anantharam P; Zaheer A
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):572-81. PubMed ID: 22035352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-33-PU.1 Transcriptome Reprogramming Drives Functional State Transition and Clearance Activity of Microglia in Alzheimer's Disease.
    Lau SF; Chen C; Fu WY; Qu JY; Cheung TH; Fu AKY; Ip NY
    Cell Rep; 2020 Apr; 31(3):107530. PubMed ID: 32320664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer's pathology in 5×FAD mice.
    Xue F; Tian J; Yu C; Du H; Guo L
    Neurobiol Dis; 2021 May; 152():105272. PubMed ID: 33540048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
    Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative gene regulatory networks modulating
    Brase L; Yu Y; McDade E; ; Harari O; Benitez BA
    medRxiv; 2024 Apr; ():. PubMed ID: 38699303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.